Phosphorylation of OTUB1 at Tyr 26 stabilizes the mTORC1 component, Raptor

被引:10
作者
Seo, Seung Un [1 ]
Woo, Seon Min [1 ]
Kim, Min Wook [2 ]
Lee, Eun-Woo [2 ,3 ]
Min, Kyoung-jin [4 ]
Kwon, Taeg Kyu [1 ,5 ]
机构
[1] Keimyung Univ, Sch Med, Dept Immunol, Daegu 42601, South Korea
[2] Korea Res Inst Biosci & Biotechnol KRIBB, Metab Regulat Res Ctr, Daejeon 34141, South Korea
[3] Univ Sci & Technol UST, Dept Funct Genom, Daejeon 34141, South Korea
[4] Daegu Gyeongbuk Med Innovat Fdn DGMIF, New Drug Dev Ctr, Daegu 41061, South Korea
[5] Keimyung Univ, Ctr Forens Pharmaceut Sci, Daegu 42601, South Korea
关键词
SIGNALING PATHWAY; CELL CARCINOMA; BREAST-CANCER; UBIQUITINATION; INHIBITION; ACTIVATION; RAPAMYCIN; KINASE;
D O I
10.1038/s41418-022-01047-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Raptor plays a critical role in mTORC1 signaling. High expression of Raptor is associated with resistance of cancer cells to PI3K/mTOR inhibitors. Here, we found that OTUB1-stabilized Raptor in a non-canonical manner. Using biochemical assays, we found that the tyrosine 26 residue (Y26) of OTUB1 played a critical role in the interaction between OTUB1 and Raptor. Furthermore, non-receptor tyrosine kinases (Src and SRMS kinases) induced phosphorylation of OTUB1 at Y26, which stabilized Raptor. Interestingly, phosphorylation of OTUB1 at Y26 did not affect the stability of other OTUB1-targeted substrates. However, dephosphorylation of OTUB1 destabilized Raptor and sensitized cancer cells to anti-cancer drugs via mitochondrial reactive oxygen species-mediated mitochondrial dysfunction. Furthermore, we detected high levels of phospho-OTUB1 and Raptor in samples of patients with renal clear carcinoma. Our results suggested that regulation of OTUB1 phosphorylation may be an effective and selective therapeutic target for treating cancers via down-regulation of Raptor.
引用
收藏
页码:82 / 93
页数:12
相关论文
共 52 条
[1]  
Battelli Chiara, 2011, Therapy, V8, P359
[2]   USP9X deubiquitylating enzyme maintains RAPTOR protein levels, mTORC1 signalling and proliferation in neural progenitors [J].
Bridges, Caitlin R. ;
Tan, Men-Chee ;
Premarathne, Susitha ;
Nanayakkara, Devathri ;
Bellette, Bernadette ;
Zencak, Dusan ;
Domingo, Deepti ;
Gecz, Jozef ;
Murtaza, Mariyam ;
Jolly, Lachlan A. ;
Wood, Stephen A. .
SCIENTIFIC REPORTS, 2017, 7
[3]   The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma (Publication with Expression of Concern. See vol. 25, pg. 4194, 2019) [J].
Cho, Daniel C. ;
Cohen, Matthew B. ;
Panka, David J. ;
Collins, Michael ;
Ghebremichael, Musie ;
Atkins, Michael B. ;
Signoretti, Sabina ;
Mier, James W. .
CLINICAL CANCER RESEARCH, 2010, 16 (14) :3628-3638
[4]   RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition [J].
Earwaker, Philip ;
Anderson, Caroline ;
Willenbrock, Frances ;
Harris, Adrian L. ;
Protheroe, Andrew S. ;
Macaulay, Valentine M. .
PLOS ONE, 2018, 13 (02)
[5]   Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion [J].
Edelmann, Mariola J. ;
Kramer, Holger B. ;
Altun, Mikael ;
Kessler, Benedikt M. .
FEBS JOURNAL, 2010, 277 (11) :2515-2530
[6]   The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1 [J].
Goel, Raghuveera K. ;
Miah, Sayem ;
Black, Kristin ;
Kalra, Natasha ;
Dai, Chenlu ;
Lukong, Kiven E. .
FEBS JOURNAL, 2013, 280 (18) :4539-4559
[7]   Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS) [J].
Goel, Raghuveera Kumar ;
Paczkowska, Marta ;
Reimand, Jueri ;
Napper, Scott ;
Lukong, Kiven Erique .
MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (05) :925-947
[8]   OTUB1 modulates c-IAP1 stability to regulate signalling pathways [J].
Goncharov, Tatiana ;
Niessen, Kyle ;
de Almagro, Maria Cristina ;
Izrael-Tomasevic, Anita ;
Fedorova, Anna V. ;
Varfolomeev, Eugene ;
Arnott, David ;
Deshayes, Kurt ;
Kirkpatrick, Donald S. ;
Vucic, Domagoj .
EMBO JOURNAL, 2013, 32 (08) :1103-1114
[9]   Defining the role of mTOR in cancer [J].
Guertin, David A. ;
Sabatini, David M. .
CANCER CELL, 2007, 12 (01) :9-22
[10]   Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1 [J].
Guertin, David A. ;
Stevens, Deanna M. ;
Thoreen, Carson C. ;
Burds, Aurora A. ;
Kalaany, Nada Y. ;
Moffat, Jason ;
Brown, Michael ;
Fitzgerald, Kevin J. ;
Sabatini, David M. .
DEVELOPMENTAL CELL, 2006, 11 (06) :859-871